Intelligence Platform
Patents
Browse 74 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 8071380
Skeletal muscle periangioblasts and cardiac mesangioblasts, method for isolation and uses
granted patentUS 7833789
Monocyte cell
granted patentUS 7812168
Purification of montelukast
granted patentUS 7795386
Peptides comprising an isoDGR motif
granted patentUS 7763292
Cancer cell growth inhibition by black bean (Phaseolus vulgaris L) extracts
granted patentUS 7737256
Antibody against uPA/uPAR
granted patentUS 7622105
Modified cytokines for use in cancer therapy
granted patentUS 7622556
Modified cytokines for use in cancer therapy
granted patentUS 7556804
Anti-HGF-R antibodies and their use
granted patentUS 7547787
Processes for preparing montelukast sodium
granted patentUS 7479483
Tumor-targeted drug delivery systems and uses thereof
granted patentUS 7476721
Modified cytokines for use in cancer therapy
granted patentUS 7309694
Modified cytokines for use in cancer therapy
granted patentUS 7268122
Use of oversulfated polysaccharides as inhibitors of HIV
granted patentUS 7164000
RANTES mutants and therapeutic applications thereof
granted patentUS 7150869
Modified cytokines for use in cancer therapy
granted patentUS 7109303
Modified cytokines for use in cancer therapy
granted patentUS 6841547
Method for decreasing low density lipoprotein
expired patentUS 6709649
RANTES derived peptides with anti-HIV activity
expired patentUS 6608177
Rantes mutants and therapeutic applications thereof
expired patentUS 6462170
UPAR mimicking peptide
expired patentUS 6429009
Composition and method of imparting resistivity to HIV superinfection to cells
expired patentUS 6194460
Composition for treating cough induced by angiotensin converting enzyme inhibitors
expired patentUS 6165738
Expression in yeast of antigenically active, recombinant hybrid glutamic acid decarboxylas
expired